What is pathophysiology of Alzheimer?

['Przesłuchejcie sie tyj strōny']

Co to je patofizjologijo Alzheimera?

Fizyjopatologijo choroby Alzheimera (AD) to słożōny proces, co ôbyjmuje akumulacyjo niyôbyczajnych biołtek, zapalynie i dysfunkcyjo neurōnōw.

Dwie głōwne cychy karakterystyczne choroby Alzheimera to ôbecność blaszek amyloidu beta (Aβ) i splotōw neurofibrylarnych (NFT) w mōzgu.

Płytki amyloidu-beta powstŏwajōm, kej fragmynta biōłtka prekursorowego amyloidu (APP) sōm rozszczypiane ôd ynzymōw do tworzyniŏ peptydōw Aβ.

Te peptydy agregowajōm sie i tworzōm nierozpuszczalne włōkiynka, kere grōmadzōm sie poza neurōnami, zaburzajōnc kōmunikacyjo miyndzy kōmōrkami i kludzōnc do śmierci neurōnōw.

Uwożo sie, iże akumulacyjo blaszek Aβ je jednym z nojwczasniyjszych zdarzyń we rozroście choroby Alzheimera i prziczynio sie do procesu neurodegeneracyjnego.

Neurofibrillarne plōntania tworzōm sie, kej biołtko tau ulega hiperfosforylacyji i tworzi niyôbyczajne włōkiynta we postrzodku neurōnōw.

Te plōntania zaburzajōm normalne funkcjōniyrowanie mikrotubuli, kere sōm zdatne do transportu skłodnikōw ôdżywczych i inkszych materyji we postrzodku neurōnu.

Te sploty na kōniec kludzōm do śmierci dotkniętych neurōnōw.

Zapalynie ôdegrowo tyż rola w patofizjologiji choroby Alzheimera.

Ukłod ôdpornościowy ryaguje na akumulacyjo blaszek Aβ i NFT bez uwolniynie prozapalnych cytokin, co mogōm pogorszyć zniszczynie neurōnōw.

Pōnadto sōm dowody na to, iże stres ôksydacyjny, dysfunkcyjo mitochōndriōw i zaburzōny metabolizm glukozy prziczyniajōm sie do patofizjologije choroby Alzheimera.

Te faktory mogōm kludzić do dysfunkcyje i śmierci neurōnōw, co jeszcze barzij zaostrzo proces chorobowy.

Ôgōlnie patofizjologijo choroby Alzheimera je słożōnym ôddziaływaniym mocy faktorōw, co na kōniec kludzōm do postympujōncego spodku funkcyje kognitywnych i utroty pamiyńci, co karakteryzuje ta choroba.

['Strōny ôdniesiyniŏ']

PubMed/Medline https://www.nlm.nih.gov/databases/download/pubmed_medline.html

RefinedWeb https://arxiv.org/abs/2306.01116

Nemeroff CB: The preeminent role of neuropeptide systems in the early pathophysiology of Alzheimer disease: up with corticotropin-releasing factor, down with acetylcholine. Arch Gen Psychiatry. 1999, 56 (11): 991-2.

Skoog I, Kalaria RN, Breteler MM: Vascular factors and Alzheimer disease. Alzheimer Dis Assoc Disord. , 13 Suppl 3 (): S106-14.

Proft J, Weiss N: Jekyll and Hide: The two faces of amyloid β. Commun Integr Biol. 2012, 5 (5): 405-7.

Whitehouse PJ, Hedreen JC, White CL, Price DL: Basal forebrain neurons in the dementia of Parkinson disease. Ann Neurol. 1983, 13 (3): 243-8.

Casadesus G, Moreira PI, Nunomura A, Siedlak SL, Bligh-Glover W, Balraj E, Petot G, Smith MA, Perry G: Indices of metabolic dysfunction and oxidative stress. Neurochem Res. , 32 (4-5): 717-22.

Candore G, Bulati M, Caruso C, Castiglia L, Colonna-Romano G, Di Bona D, Duro G, Lio D, Matranga D, Pellicanò M, Rizzo C, Scapagnini G, Vasto S: Inflammation, cytokines, immune response, apolipoprotein E, cholesterol, and oxidative stress in Alzheimer disease: therapeutic implications. Rejuvenation Res. , 13 (2-3): 301-13.

Raskind MA, Peskind ER: Neurobiologic bases of noncognitive behavioral problems in Alzheimer disease. Alzheimer Dis Assoc Disord. 1994, 8 Suppl 3 (): 54-60.

Schindler SE, McConathy J, Ances BM, Diamond MI: Advances in diagnostic testing for Alzheimer disease. Mo Med. , 110 (5): 401-5.

Singh VK: Immune-activation model in Alzheimer disease. Mol Chem Neuropathol. , 28 (1-3): 105-11.

['Zrzeczynie sie: medyczne']

['Ta strōna internetowo je dostympno ino we cylu edukacyjnym i informacyjnym i niy stanowi doradztwa medycznego ani profesjonalnych usug.']

['Informacyje podane niy winny być używane do diagnozowanio abo lyczynio problymu abo choroby, a ôsoby szukajōnce ôsobistej pōmocy medycznyj winny skōntrolować sie z licencjōnowanym medykiym.']

['Należy pamiyntać, iże neuralno neca, co gyneruje ôdpowiedzi na pytania, je ekstra niydokładno, kej sie rozchodzi ô treść numeryczno, bp. liczba ôsōb ze zdiagnozowanōm kōnkretnōm chorobōm.']

['Dycki szukejcie pōmocy u swojigo medyka abo inkszego wykwalifikowanego dochtora we sprawie stanu medycznego. Niy lekcewożcie profesjonalnyj rady medycznyj ani niy ôpōźnijcie sie z szukaniym jij skuli czegoś, co żeście poczytali na tyj strōnie. Jeźli myślicie, iże mogōm mieć niybezpieczyństwo medyczne, zazwōńcie na 911 abo udajcie sie zaroz do nojbliższyj izby wytrzyźwiyń. Żodno relacyjo medyk-pacjynt niy ma stworzōno bez ta strōna abo jeji użycie. Ani BioMedLib, ani jeji robotniki, ani żodyn inkszy autor tyj strōny niy skłodo żodnych zapewniyń, wyrażōnych ani dorozumianych, w ôdniesiyniu do informacyji podanych tukej abo do jeji użycio.']

['Ôdŏwanie praw autorskich']

['Digital Millennium Copyright Act z 1998 roku, 17 U.S.C. § 512 (the DMCA) zapewnio prawo do regresu posiedzicielōm praw autorskich, kerzi uwożajōm, iże materyjo ukazujōnco sie w Internecie naruszo jejich prawa na mocy amerykańskigo prawa autorskigo. ']

['Jeźli wierzicie w dobryj wierze, iże jake ino treści abo materyje udostympniōne w zwiōnzku z naszom witrynōm abo naszymi usugami naruszajōm wasze prawa autorskie, możecie (abo wasz przedstawiciel) posłać nōm zawiadōmiynie z prośbōm ô usuniyńcie tych treści abo materyji abo zablokowanie do nich dostympu.']

['Zawiadōmiynia muszōm być posłane we formie pisymnyj bez email (adres email zob. sekcyjŏ "Kōntakt").']

['DMCA wymogo, coby Twoje zawiadōmiynie ô rzekōmyj naruszynie praw autorskich zawiyrało nastympujōnce informacyje: (1) ôpis roboty chroniōnyj prawami autorskimi, co je przedmiotym rzekōmyj naruszynio; (2) ôpis rzekōmyj naruszajōncyj zawartości i informacyje stykajōnce, coby przizwolić nōm na zlokalizowanie zawartości; (3) informacyje kōntaktowe ô Tobie, w tym Twōj adres, numer telefonu i adres e-mail; (4) ôświadczynie ôd Ciebie, iże wiysz we dobro wierze, iże zawartość we spōsobie, co ô nim sie skarżysz, niy ma autoryzowano ôd posiedziciela praw autorskich abo jego agynta, ani bez żodne prawo.']

['5) oświadczynie złożōne bez Ciebie, podpisane pod sztrŏfōm fałszywyj ôświadczyniŏ, iże informacyje zawarte we zawiadōmiyniu sōm akuratne i iże posiadasz uprawniynia do egzekwowaniŏ uprawniyń, co ône sōm rzekōmo naruszane;']

['i (6) fizyczny abo elektrōniczny podpis posiedziciela praw autorskich abo ôsoby upoważniōnyj do fungowanio w jego imiyniu. ']

['Niyôstawiynie wszyjskich powyższych informacyji może skutkować ôpōźniyniym we rozpatrzeniu skargi.']

['Kōnakt']

['Proszymy ô e-mail z kożdym pytaniym abo sugestijōm.']

What is pathophysiology of alzheimer?

The pathophysiology of Alzheimer's disease (AD) is a complex process that involves the accumulation of abnormal proteins, inflammation, and neuronal dysfunction.

The two main hallmarks of AD are the presence of amyloid-beta (Aβ) plaques and neurofibrillary tangles (NFTs) in the brain.

Amyloid-beta plaques are formed when fragments of the amyloid precursor protein (APP) are cleaved by enzymes to form Aβ peptides.

These peptides aggregate and form insoluble fibrils that accumulate outside neurons, disrupting cell-to-cell communication and leading to neuronal death.

The accumulation of Aβ plaques is thought to be one of the earliest events in the development of AD, and it is believed to contribute to the neurodegenerative process.

Neurofibrillary tangles are formed when the protein tau becomes hyperphosphorylated and forms abnormal filaments inside neurons.

These tangles disrupt the normal functioning of the microtubules, which are essential for the transport of nutrients and other materials within the neuron.

The tangles eventually lead to the death of the affected neurons.

Inflammation also plays a role in the pathophysiology of AD.

The immune system responds to the accumulation of Aβ plaques and NFTs by releasing pro-inflammatory cytokines, which can exacerbate the damage to neurons.

Additionally, there is evidence that oxidative stress, mitochondrial dysfunction, and impaired glucose metabolism contribute to the pathophysiology of AD.

These factors can lead to neuronal dysfunction and death, further exacerbating the disease process.

Overall, the pathophysiology of AD is a complex interplay of multiple factors that ultimately lead to the progressive decline in cognitive function and memory loss that characterizes the disease.

Disclaimer: medical

This web site is provided for educational and informational purposes only and does not constitute providing medical advice or professional services.

The information provided should not be used for diagnosing or treating a health problem or disease, and those seeking personal medical advice should consult with a licensed physician.

Please note the neural net that generates answers to the questions, is specially inaccurate when it comes to numeric content. For example, the number of people diagnosed with a specific disease.

Always seek the advice of your doctor or other qualified health provider regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website. If you think you may have a medical emergency, call 911 or go to the nearest emergency room immediately. No physician-patient relationship is created by this web site or its use. Neither BioMedLib nor its employees, nor any contributor to this web site, makes any representations, express or implied, with respect to the information provided herein or to its use.

Disclaimer: copyright

The Digital Millennium Copyright Act of 1998, 17 U.S.C. § 512 (the “DMCA”) provides recourse for copyright owners who believe that material appearing on the Internet infringes their rights under U.S. copyright law. If you believe in good faith that any content or material made available in connection with our website or services infringes your copyright, you (or your agent) may send us a notice requesting that the content or material be removed, or access to it blocked. Notices must be sent in writing by email (see 'Contact' section for email address) . The DMCA requires that your notice of alleged copyright infringement include the following information: (1) description of the copyrighted work that is the subject of claimed infringement; (2) description of the alleged infringing content and information sufficient to permit us to locate the content; (3) contact information for you, including your address, telephone number and email address; (4) a statement by you that you have a good faith belief that the content in the manner complained of is not authorized by the copyright owner, or its agent, or by the operation of any law; (5) a statement by you, signed under penalty of perjury, that the information in the notification is accurate and that you have the authority to enforce the copyrights that are claimed to be infringed; and (6) a physical or electronic signature of the copyright owner or a person authorized to act on the copyright owner’s behalf. Failure to include all of the above information may result in the delay of the processing of your complaint.